Rakuoria Pharmaceutical - Rebound, heading towards a capital and business alliance with South Korea's HK inno.N Corporation.
A rebound has been announced regarding the capital and business partnership agreement with South Korea's HK inno.N Corporation. Additionally, a third-party allotment capital increase will be conducted, allotting HK inno.N Corporation as the allottee, with a payment deadline of April 18 and an issue price of 397 yen, comprising 2,592,100 shares of common stock (the voting rights ratio after fundraising is 10.62%). The amount of funds to be procured (estimated net amount) is 1,017 million yen, which will be used for the foundational management of the drug discovery business.
(INHD) - Analyzing Inno Holdings's Short Interest
Looking Into Inno Holdings's Recent Short Interest
MY Stock Buybacks Daily Wrap - 16 Aug 2024
Express News | SDG Soars 6.51% to RM4.58 Amid a Surge in Palm Oil Exports and Increased Production
6 Malaysian Stocks Launch IPOs Since June 2024, Top Gainer Skyrockets Over 185% on First Day!